Protonic Acid/Viscosity-Activatable Type-I Photosensitizer via Donor and π-Bridge Modulation for Second Near-Infrared Imaging-Guided Photodynamic and Photothermal Therapy
Analytical Chemistry · 13.01.2026 · 98 (1) · 1098-1109
DOI: 10.1021/acs.analchem.5c06671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 26.12.2025. Verfasst von Shuai Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Resource Engineering, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing…. Hauptthemen laut MEDLINE: Photosensitizing Agents, Photochemotherapy, Photothermal Therapy, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National High Level Hospital Clinical Research Funding.
Abstract (Originalsprache)
Organic small molecules activated by the tumor microenvironment (TME) exhibit significant advantages over traditional organic small molecules in cancer diagnosis and therapy. This "on-demand activation" mode substantially reduces phototoxic damage to normal tissues. In this study, a protonic acid/viscosity-activatable Type-I theranostic probe TB-pH was rationally designed through a strategy of adjusting the donor unit and π-bridge structure. Owing to the lack of effective intramolecular charge transfer (ICT), TB-pH remains silent under normal physiological conditions. Upon specific activation by the protonic acid "key" in the TME, the molecule undergoes electronic rearrangement to form TB-H with a donor-π-acceptor (D-π-A) structure. The activated TB-H molecule exhibits excellent Type-I (•OH) reactive oxygen species (ROS) generation, photothermal conversion, and NIR-II fluorescent emission capabilities under 808 nm laser irradiation. After cancer cell death induced by phototherapy, the increased intracellular viscosity in the tumor region leads to further enhancement of NIR-II emission of TB-H, providing an intuitive and effective method for real-time evaluation of tumor therapeutic efficacy. This study offers a new insight for developing protonic acid/viscosity-activatable specific photosensitizers with integrated NIR-II FL/PTT/PDT (Type-I) capabilities in the field of precise cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Resource Engineering, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing 100029, P. R. China.
ORCID-Profile: Fang Sun, Yincheng Chang
Förderung
- National Key Research and Development Program of China
- National High Level Hospital Clinical Research Funding
Zitieren
APA
Zhao, S., Liu, Y., Liu, R., Zhao, J., Sun, F., Nie, J., & Chang, Y. (2026). Protonic Acid/Viscosity-Activatable Type-I Photosensitizer via Donor and π-Bridge Modulation for Second Near-Infrared Imaging-Guided Photodynamic and Photothermal Therapy. Analytical Chemistry, 98(1), 1098-1109. https://doi.org/10.1021/acs.analchem.5c06671
Vancouver
Zhao S, Liu Y, Liu R, Zhao J, Sun F, Nie J, et al. Protonic Acid/Viscosity-Activatable Type-I Photosensitizer via Donor and π-Bridge Modulation for Second Near-Infrared Imaging-Guided Photodynamic and Photothermal Therapy. Analytical Chemistry. 2026;98(1):1098-1109. doi:10.1021/acs.analchem.5c06671
BibTeX
@article{Zhao2026,
author = {Zhao, Shuai and Liu, Yan and Liu, Ruixin and Zhao, Jie and Sun, Fang and Nie, Jun and Chang, Yincheng},
title = {Protonic Acid/Viscosity-Activatable Type-I Photosensitizer via Donor and π-Bridge Modulation for Second Near-Infrared Imaging-Guided Photodynamic and Photothermal Therapy},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {1},
pages = {1098--1109},
doi = {10.1021/acs.analchem.5c06671}
}
EUVIMED